CD70 and lymphoma: Single-cell transcriptomics confirms this approach prevents exhaustion and restores antitumor efficacy in lymphoma PDX models, while simultaneously reducing renal toxicity by eliminating CD70 from T cells that could exacerbate off-target damage (72).